Multimode Trans-scale Biomedical Imaging Facilities is a construction project identified in the "Thirteenth Five-Year Plan" for the Construction of National Major Scientific and Technological Infrastructure, and it is a large-scale scientific facility in the field of biomedical imaging initiated by Chinese scientists. As the project's legal entity construction unit, Peking University, in collaboration with the Institute of Institute of Biophysics， Chinese Academy of Sciences, Harbin Institute of Technology, University of Science and Technology of China, Institute of Physics CAS，and The Institute of High Energy Physics of the Chinese Academy of Sciences, jointly undertake the construction task. The total investment in the project is 1.717 billion yuan. The construction site is located in the core area of Huairou Science City in Beijing, with a construction land of 100 acres and a newly added construction area of 72,000 square meters. The project is expected to be completed in 2024.

The goal of the imaging facility is to break through the scale barrier, with principle innovation and independent integration as the main focus. Through research and development and organic integration of different imaging modalities, a seamless, integrated biomedical imaging technology cluster from molecules to humans is created in terms of time and space scales and modalities. The facility consists of four core devices and one auxiliary platform, including Multimode Medical Imaging Platform, Multimode Live System Imaging Platform, Multimode High-Resolution Molecular Imaging Platform, Multimode Trans-scale Image Data Integration System, and auxiliary platforms such as Animal Model Platform and supporting facilities. Through interconnection and intercommunication, the imaging facility will cover a scale range spanning nine orders of magnitude, forming a trans-scale, multimode, automated, and high-throughput biomedical imaging research platform, becoming a world-class biomedical imaging facility in comprehensive capabilities.

The imaging facility will implement an open, flow, and selection mechanism, open and shared to the whole country, and will also establish an international alliance with biomedical imaging platforms in the United States, the European Union, and other places. The imaging facility will provide imaging omics research methods for complex life science problems and major diseases, conduct panoramic research and analysis of major biomedical scientific problems, and promote the paradigm shift of biomedical research. At the same time, the imaging facility will become a national base for leading and driving technological and methodological innovations. It will establish an industrial innovation alliance with universities, research institutes, biomedical imaging equipment, software, and probe companies to create an innovative ecosystem for biomedical imaging technology "industry-university-research-application." This will provide strategic support and guarantees for realizing "Created in China" of high-end biomedical imaging equipment.